{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T17:49:00Z","timestamp":1709315340227},"reference-count":100,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CLIN INFECT DIS"],"published-print":{"date-parts":[[2008,6,15]]},"DOI":"10.1086\/588475","type":"journal-article","created":{"date-parts":[[2008,5,8]],"date-time":"2008-05-08T21:56:15Z","timestamp":1210283775000},"page":"1889-1901","source":"Crossref","is-referenced-by-count":40,"title":["Clinical Practice: Combination Antifungal Therapy for Mold Infections: Much Ado about Nothing?"],"prefix":"10.1093","volume":"46","author":[{"given":"Jose\u00a0A.","family":"Vazquez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"rf1_295","first-page":"183","volume":"7","author":"Kullberg BJ","year":"2002","journal-title":"Eur J Med Res"},{"key":"rf2_296","doi-asserted-by":"publisher","DOI":"10.1086\/497138"},{"key":"rf3_297","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1128\/CMR.12.1.40","volume":"12","author":"Sheehan DJ","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"rf4_298","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2004.00167.x"},{"key":"rf5_299","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.4.2.325"},{"key":"rf6_300","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1742-1241.2001.tb11144.x","volume":"55","author":"Graybill JR","year":"2001","journal-title":"Int J Clin Pract"},{"key":"rf7_301","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.18.1.163-194.2005"},{"key":"rf8_302","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.3.693-715.2004"},{"key":"rf9_303","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/infdis\/137.2.122","volume":"137","author":"Berenbaum MC","year":"1978","journal-title":"J Infect Dis"},{"key":"rf10_304","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.3.702-707.2002"},{"key":"rf11_305","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.6.2007-2013.2004"},{"key":"rf12_306","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.10.2915-2918.2000"},{"key":"rf13_307","doi-asserted-by":"publisher","DOI":"10.1007\/s101560050021"},{"key":"rf14_308","unstructured":"Ghannoum MA, Catalano V, Isham N. In vitro testing of abelcet in combination with other antifungals [abstract M-1794]. In: Program and abstracts of the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 2004. Washington DC: American Society for Microbiology, 2004."},{"key":"rf15_309","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2006.07.011"},{"key":"rf16_310","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01024-06"},{"key":"rf17_311","doi-asserted-by":"publisher","DOI":"10.1080\/714030977"},{"key":"rf18_312","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkf111"},{"key":"rf19_313","unstructured":"Manavathu EK, Ganesan LT, Cutright JL, Chandrasekar PH. In vitro antifungal activity of voriconazole in two-drug combinations with micafungin, caspofungin, and amphotericin B [abstract J-125]. In: Program and abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. Washington DC: American Society for Microbiology, 2001."},{"key":"rf20_314","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.1.245-247.2002"},{"key":"rf21_315","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.9.3039-3041.2002"},{"key":"rf22_316","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.4.1416-1418.2003"},{"key":"rf23_317","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg242"},{"key":"rf24_318","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(03)00136-6"},{"key":"rf25_319","unstructured":"Sabatelli F. In vitro and in vivo interaction of posaconazole (POS) and caspofungin (CSP) against Aspergillus [abstract M-990]. In: Program and abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. Washington DC: American Society for Microbiology, 2003."},{"key":"rf26_320","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl392"},{"key":"rf27_321","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.3.970-978.2004"},{"key":"rf28_322","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.3.1232-1235.2005"},{"key":"rf29_323","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki343"},{"key":"rf30_324","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.8.3572-3574.2005"},{"key":"rf31_325","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.12.3310-3321.2001"},{"key":"rf32_326","doi-asserted-by":"publisher","DOI":"10.1007\/BF01700417"},{"key":"rf33_327","doi-asserted-by":"crossref","unstructured":"Van't Hof W, Reijnders IM, Helmerhorst EJ, etal Synergistic effects of low doses of histatin 5 and its analogues on amphotericin B anti-mycotic activity. Antonie van Leeuwenhoek 2000; 78:163-9.","DOI":"10.1023\/A:1026572128004"},{"key":"rf34_328","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.4.1335-1343.2004"},{"key":"rf35_329","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.5.1664-1669.2004"},{"key":"rf36_330","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.11.3592-3597.2003"},{"key":"rf37_331","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/AAC.11.1.21","volume":"11","author":"Arroyo J","year":"1977","journal-title":"Antimicrob Agents Chemother"},{"key":"rf38_332","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1439-0507.1991.tb00660.x","volume":"34","author":"Schmitt HJ","year":"1991","journal-title":"Mycoses"},{"key":"rf39_333","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.10.3208-3214.2002"},{"key":"rf40_334","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.3.758-764.2004"},{"key":"rf41_335","doi-asserted-by":"publisher","DOI":"10.1086\/506617"},{"key":"rf42_336","unstructured":"Gavalda J, Lopez P, Martin MT, etal Evaluation of combination of voriconazole (Vz) + terbinafine (Tb) in the treatment of experimental pulmonary aspergillosis (EPA) [abstract M-224]. In: Program and Abstracts of the 44th Interscience Conference on Antimicrobials Agents and Chemotherapy. Washington DC: American Society for Microbiology, 2004."},{"key":"rf43_337","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.11.4751-4753.2005"},{"key":"rf44_338","unstructured":"Kohno S, Maesaki S, Iwakawa J, etal Synergistic effects of combination of FK463 with amphotericin B: enhanced efficacy in murine model of invasive pulmonary aspergillosis [abstract M-1686]. In: Program and Abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada. Washington DC: American Society for Microbiology, 2000."},{"key":"rf45_339","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.8.2564-2568.2002"},{"key":"rf46_340","doi-asserted-by":"publisher","DOI":"10.1086\/375420"},{"key":"rf47_341","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg425"},{"key":"rf48_342","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.4.1452-1455.2003"},{"key":"rf49_343","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2004.00958.x"},{"key":"rf50_344","unstructured":"Chandrasekar P, Krishnan S, Cutright J, etal A comparative study of the in vivo efficacy of amphotericin B lipid complex alone and in combination with caspofungin against Aspergillus fumigatus in a murine pulmonary aspergillosis model [abstract M-231]. In: Program and abstracts of the 44th Interscience Conference on Antifungal Agents and Chemotherapy. Washington DC: American Society for Microbiology, 2004."},{"key":"rf51_345","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.12.4867-4875.2005"},{"key":"rf52_346","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl236"},{"key":"rf53_347","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.9.3697-3701.2005"},{"key":"rf54_348","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.2.422-427.2006"},{"key":"rf55_349","unstructured":"Olson JA, Constable DS, Smith PJ, etal Comparative vs sequential therapy with liposomal amphotericin B (LAmB) and micafungin (Mc) in murine systemic aspergillosis [abstract M-1746]. In: Program and abstracts of the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA. Washington DC: American Society for Microbiology, 2006."},{"key":"rf56_350","unstructured":"Petraitis V, Petratiene R, Hope W, etal Combination therapy of voriconazole and anidulafungin improves outcome of experimental pulmonary aspergillosis [abstract M-882]. In: Program and abstracts of the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA. Washington DC: American Society for Microbiology, 2006."},{"key":"rf57_351","doi-asserted-by":"publisher","DOI":"10.1001\/jama.241.22.2418"},{"key":"rf58_352","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1439-0507.1993.tb00732.x","volume":"36","author":"Schaffner A","year":"1993","journal-title":"Mycoses"},{"key":"rf59_353","doi-asserted-by":"publisher","DOI":"10.1592\/phco.19.1.118.30511"},{"key":"rf60_354","unstructured":"Kontoyiannis DP, Hachem R, Lewis RE, Rivero G, Kantarjian H, Raad II. Efficacy and toxicity of the caspofungin\/liposomal amphotericin B (CAS\/LipoAMB) combination in documented or possible invasive aspergillosis (IA) in patients (Pts) with hematologic malignancies [abstract M-1820]. In: Program and abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA. Washington DC: American Society for Microbiology, 2002."},{"key":"rf61_355","doi-asserted-by":"publisher","DOI":"10.1086\/423380"},{"key":"rf62_356","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21057"},{"key":"rf63_357","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22348"},{"key":"rf64_358","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000202421.94822.f7"},{"key":"rf65_359","unstructured":"Raad II, Hanna H, Boktour M, etal The combination of caspofungin (C) and voriconazole (V) as primary and salvage therapy of invasive aspergillosis (IA) in hematologic malignancy patients (HMP) [abstract M-889]. In: Program and abstracts of the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA. Washington DC: American Society for Microbiology, 2006."},{"key":"rf66_360","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2006.03.003"},{"key":"rf67_361","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.10.4898-4900.2003"},{"key":"rf68_362","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-003-0795-x"},{"key":"rf69_363","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1D292"},{"key":"rf70_364","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-002-0781-6"},{"key":"rf71_365","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704485"},{"key":"rf72_366","first-page":"R39","volume":"90","author":"Vazquez L","year":"2005","journal-title":"Haematologia"},{"key":"rf73_367","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2006.01299.x"},{"key":"rf74_368","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.8.3981-3985.2003"},{"key":"rf75_369","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10096-002-0877-z","volume":"22","author":"Howden BP","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"rf76_370","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0507.2003.00878.x"},{"key":"rf77_371","doi-asserted-by":"publisher","DOI":"10.1080\/00365540600786564"},{"key":"rf78_372","doi-asserted-by":"publisher","DOI":"10.1086\/515042"},{"key":"rf79_373","first-page":"2315","volume":"133","author":"Elorza M","year":"1987","journal-title":"J Gen Microbiol"},{"key":"rf80_374","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2004.00996.x"},{"key":"rf81_375","unstructured":"Cordoba S, Vivot W, Abrantes R, etal In vitro interactions with antifungal agents against Fusarium spp [abstract M-243]. In: Program and abstracts of the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC: American Society for Microbiology, 2004."},{"key":"rf82_376","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.12.5157-5159.2005"},{"key":"rf83_377","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1128\/AAC.43.6.1401","volume":"43","author":"Li RK","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"rf84_378","unstructured":"Torres HA, Kontoyiannis DP. Hyalohyphomycosis (other than aspergillosis and penicilliosis). In: Dismukes WM, Pappas PG, Sobel JD, eds. Clinical mycology. New York, NY: Oxford University Press, 2003:252-270."},{"key":"rf85_379","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.8.2708-2711.2002"},{"key":"rf86_380","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.1.96-103.2006"},{"key":"rf87_381","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00595-07"},{"key":"rf88_382","doi-asserted-by":"publisher","DOI":"10.1086\/432579"},{"key":"rf89_383","unstructured":"Ibrahim AS, Edwards JE, Filler SG. Zygomycosis. In: Dismukes WM, Pappas PG, Sobel JD, eds. Clinical mycology. New York, NY: Oxford University Press, 2003:241-251."},{"key":"rf90_384","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00452-07"},{"key":"rf91_385","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.2.830-832.2005"},{"key":"rf92_386","doi-asserted-by":"publisher","DOI":"10.1086\/426445"},{"key":"rf93_387","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.7.2151-2153.2001"},{"key":"rf94_388","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.1.62-68.2002"},{"key":"rf95_389","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1128\/AAC.39.6.1361","volume":"39","author":"Walsh TJ","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"rf96_390","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.2.470-472.2000"},{"key":"rf97_391","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.1.106-117.2003"},{"key":"rf98_392","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.8.3498-3500.2005"},{"key":"rf99_393","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.10.3323-3326.2002"},{"key":"rf100_394","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.12.5139-5141.2005"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/46\/12\/1889\/846258\/46-12-1889.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T01:11:44Z","timestamp":1708909904000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1086\/588475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,15]]},"references-count":100,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,6,15]]}},"alternative-id":["10.1086\/588475"],"URL":"https:\/\/doi.org\/10.1086\/588475","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,15]]}}}